SCHEMBL16664934

SCHEMBL16664934

CCCNc1cc(-c2cnc(NC)c(C#N)c2)ncn1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 11/20 0.39
ALDH1A1 P00352 11/20 0.39
HSD17B10 Q99714 8/20 0.39
CYP2C19 P33261 8/20 0.39
CLK4 Q9HAZ1 8/20 0.39
MAPK1 P28482 5/20 0.39
USP2 O75604 3/20 0.39
CYP3A4 P08684 10/20 0.39
CYP2D6 P10635 6/20 0.39
HPGD P15428 5/20 0.39
KDM4E B2RXH2 4/20 0.39
TSHR P16473 3/20 0.39
MAPT P10636 2/20 0.39
SMN1; SMN2 Q16637 3/20 0.36
FLT3 P36888 2/20 0.36
TYRO3 Q06418 2/20 0.36
MERTK Q12866 2/20 0.36
GAS6 Q14393 2/20 0.36
FAAH O00519 1/20 0.35
LMNA P02545 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16664971 0.75 CYP1A2 (0.46) CYP1A2ALDH1A1HSD17B10CYP2C19CLK4
SCHEMBL16664979 0.70 FAAH (0.39) CYP1A2ALDH1A1HSD17B10CYP2C19CLK4
SCHEMBL16665010 0.70 FAAH (0.41) CYP1A2ALDH1A1HSD17B10CYP2C19CLK4
SCHEMBL16664909 0.69 CYP1A2 (0.43) CYP1A2ALDH1A1HSD17B10CYP2C19CLK4
SCHEMBL16664919 0.69 PIK3CA (0.44) CYP1A2ALDH1A1HSD17B10CYP2C19CLK4
SCHEMBL16664969 0.69 KDM4E (0.47) CYP1A2ALDH1A1HSD17B10CYP2C19CLK4
SCHEMBL15343048 0.69 KDM4E (0.47) CYP1A2ALDH1A1HSD17B10CYP2C19CLK4
SCHEMBL18902711 0.69 CYP1A2 (0.53) CYP1A2ALDH1A1HSD17B10CYP2C19CLK4
SCHEMBL16664987 0.69 CYP1A2 (0.46) CYP1A2ALDH1A1HSD17B10CYP2C19CLK4
SCHEMBL16664949 0.69 FLT3 (0.39) CYP1A2ALDH1A1HSD17B10CYP2C19CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015058031-A1 DNA-PK INHIBITORS VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-04-23 WO disclosed